Sara Martí
Biographic Data
| ID | 7883161 |
|---|---|
| NAME | Sara Martí |
| GIVEN NAMES | Sara |
| FAMILY NAME | Martí |
| SIGNATURE | MARTI S |
| AFFILIATIONS | Instituto de Salud Carlos III |
| ORCID | 0000-0002-0405-2305 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Gut microbiome shift in long Covid: Impact of disease and montelukast treatment
Background: Long COVID-19 is a post-infectious syndrome with persistent symptoms that can involve multiple organ systems. Evidence suggests that SARS-CoV-2 infection may disrupt gut microbiome composition, potentially contributing to long-term effects. As treatment remains symptom-based, interest has grown in repurposing drugs like montelukast. However, non-antibiotic medications may also alter gut microbial communities, raising questions about t…
Mathematical modeling of Sars-CoV-2 variant substitutions in European countries: Transmission dynamics and epidemiological insights
Background Countries across Europe have faced similar evolutions of SARS-CoV-2 variants of concern, including the Alpha, Delta, and Omicron variants. Materials and methods We used data from GISAID and applied a robust, automated mathematical substitution model to study the dynamics of COVID-19 variants in Europe over a period of more than 2 years, from late 2020 to early 2023. This model identifies variant substitution patterns and distinguishes …
Prevalence of Sars-CoV-2 Infection at the University of Barcelona during the Third Covid-19 Pandemic Wave in Spain
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic started in December 2019 and still is a major global health challenge. Lockdown measures and social distancing sparked a global shift towards online learning, which deeply impacted universities' daily life, and the University of Barcelona (UB) was not an exception. Accordingly, we aimed to determine the impact of the SARS-CoV-2 pandemic at the UB. To that end, we performed …
No prominent works on this page.
Prevalence of Sars-CoV-2 Infection at the University of Barcelona during the Third Covid-19 Pandemic Wave in Spain
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic started in December 2019 and still is a major global health challenge. Lockdown measures and social distancing sparked a global shift towards online learning, which deeply impacted universities' daily life, and the University of Barcelona (UB) was not an exception. Accordingly, we aimed to determine the impact of the SARS-CoV-2 pandemic at the UB. To that end, we performed …
Mathematical modeling of Sars-CoV-2 variant substitutions in European countries: Transmission dynamics and epidemiological insights
Background Countries across Europe have faced similar evolutions of SARS-CoV-2 variants of concern, including the Alpha, Delta, and Omicron variants. Materials and methods We used data from GISAID and applied a robust, automated mathematical substitution model to study the dynamics of COVID-19 variants in Europe over a period of more than 2 years, from late 2020 to early 2023. This model identifies variant substitution patterns and distinguishes …
Gut microbiome shift in long Covid: Impact of disease and montelukast treatment
Background: Long COVID-19 is a post-infectious syndrome with persistent symptoms that can involve multiple organ systems. Evidence suggests that SARS-CoV-2 infection may disrupt gut microbiome composition, potentially contributing to long-term effects. As treatment remains symptom-based, interest has grown in repurposing drugs like montelukast. However, non-antibiotic medications may also alter gut microbial communities, raising questions about t…
Coronavirus (2 works) · Disease (2 works) · Medicine (2 works) · SARS-CoV-2 detection and testing (2 works) · 2019-20 coronavirus outbreak (1 works) · Algorithm (1 works) · Artificial Intelligence (1 works) · Betacoronavirus (1 works) · Computer Science (1 works) · Coronavirus disease 2019 (COVID-19 (1 works)